|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of ACACA mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of ADIPOQ protein] |
CTD |
PMID:32652086 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Agrp |
agouti related neuropeptide |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of AGRP mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr19:33,447,992...33,481,602
Ensembl chr19:33,447,992...33,449,584
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of AKT1 mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [APP protein modified form results in increased uptake of Calcium] |
CTD |
PMID:24457011 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased expression of ATG5 protein] |
CTD |
PMID:34308505 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased expression of ATG7 protein] |
CTD |
PMID:34308505 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
[Aconitine co-treated with Ruthenium Red] results in increased expression of BAX protein |
CTD |
PMID:37506855 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [Dronabinol affects the secretion of CALCA protein] |
CTD |
PMID:17828286 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO |
[Verapamil co-treated with Ruthenium Red co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Trichlorfon results in increased cleavage of and results in increased activity of CASP12 protein] |
CTD |
PMID:19631781 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[Verapamil co-treated with Ruthenium Red co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Trichlorfon results in increased cleavage of and results in increased activity of CASP3 protein]; Ruthenium Red inhibits the reaction [allyl isothiocyanate results in decreased cleavage of CASP3 protein] [Aconitine co-treated with Ruthenium Red] results in increased cleavage of CASP3 protein |
CTD |
PMID:19631781 PMID:23219522 PMID:37506855 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cck |
cholecystokinin |
multiple interactions |
ISO |
[N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine co-treated with Ruthenium Red] inhibits the reaction [deoxynivalenol results in increased expression of CCK protein]; Ruthenium Red inhibits the reaction [deoxynivalenol results in increased expression of CCK protein] |
CTD |
PMID:26979077 |
|
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of GHRL protein] |
CTD |
PMID:32652086 |
|
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of GHSR mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
|
|
G |
Grm1 |
glutamate metabotropic receptor 1 |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein]; Ruthenium Red inhibits the reaction [[3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein] which results in increased abundance of Calcium] |
CTD |
PMID:14622174 |
|
NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [IGF1 protein results in increased secretion of VEGFA protein] |
CTD |
PMID:20539001 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Capsaicin results in increased expression of IL6 mRNA] Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of IL6 protein] |
CTD |
PMID:16173059 PMID:32652086 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [INS protein results in increased uptake of cobaltous chloride] |
CTD |
PMID:14622148 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of LEP protein] |
CTD |
PMID:32652086 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:34308505 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP ISO |
Ruthenium Red inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] Ruthenium Red inhibits the reaction [[allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK1 protein]; Ruthenium Red inhibits the reaction [Aflatoxin B1 results in increased phosphorylation of MAPK1 protein]; Ruthenium Red inhibits the reaction [allyl isothiocyanate results in increased phosphorylation of MAPK1 protein]; Ruthenium Red inhibits the reaction [Formaldehyde results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:16513848 PMID:23219522 PMID:23994502 PMID:27818125 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO EXP |
Ruthenium Red inhibits the reaction [[allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK3 protein]; Ruthenium Red inhibits the reaction [Aflatoxin B1 results in increased phosphorylation of MAPK3 protein]; Ruthenium Red inhibits the reaction [allyl isothiocyanate results in increased phosphorylation of MAPK3 protein]; Ruthenium Red inhibits the reaction [Formaldehyde results in increased phosphorylation of MAPK3 protein] Ruthenium Red inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:16513848 PMID:23219522 PMID:23994502 PMID:27818125 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mcu |
mitochondrial calcium uniporter |
multiple interactions |
ISO |
[Aconitine co-treated with Ruthenium Red] results in increased expression of MCU protein |
CTD |
PMID:37506855 |
|
NCBI chr20:27,417,529...27,580,110
Ensembl chr20:27,417,526...27,580,110
|
|
G |
Mfn2 |
mitofusin 2 |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [Phenylephrine results in decreased expression of MFN2 protein] |
CTD |
PMID:20886221 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Micu1 |
mitochondrial calcium uptake 1 |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [tianhuang inhibits the reaction [Dexamethasone results in decreased expression of MICU1 protein]]; Ruthenium Red promotes the reaction [Dexamethasone results in decreased expression of MICU1 protein] |
CTD |
PMID:37337224 |
|
NCBI chr20:27,668,681...27,816,322
Ensembl chr20:27,668,747...27,814,964
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
affects expression multiple interactions |
ISO |
Ruthenium Red affects the expression of MMP1 mRNA; Ruthenium Red affects the expression of MMP1 protein Ruthenium Red inhibits the reaction [Vehicle Emissions results in increased secretion of MMP1 protein] |
CTD |
PMID:17508023 PMID:21245013 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [cinnamaldehyde results in increased activity of MPO protein]; Ruthenium Red inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] |
CTD |
PMID:21466812 PMID:22882778 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of NFKB1 mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
Ruthenium Red inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:20886221 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Npy |
neuropeptide Y |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of NPY mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of PIK3R1 mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of POMC mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [tianhuang inhibits the reaction [Dexamethasone results in decreased expression of and results in decreased phosphorylation of PRKAA1 protein]]; Ruthenium Red promotes the reaction [Dexamethasone results in decreased expression of and results in decreased phosphorylation of PRKAA1 protein] |
CTD |
PMID:37337224 |
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Prkag2 |
protein kinase AMP-activated non-catalytic subunit gamma 2 |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of PRKAG2 mRNA] |
CTD |
PMID:32652086 |
|
NCBI chr 4:10,010,890...10,252,155
Ensembl chr 4:10,010,890...10,252,142
|
|
G |
Pyy |
peptide YY |
multiple interactions |
ISO |
[Ruthenium Red co-treated with N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine] inhibits the reaction [deoxynivalenol results in increased expression of PYY protein alternative form]; Ruthenium Red inhibits the reaction [deoxynivalenol results in increased expression of PYY protein alternative form] |
CTD |
PMID:26979077 |
|
NCBI chr10:87,061,155...87,062,278
Ensembl chr10:87,061,161...87,061,815
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of TNF protein] |
CTD |
PMID:32652086 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
multiple interactions decreases activity |
ISO |
Ruthenium Red inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [[allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK1 protein]; Ruthenium Red inhibits the reaction [[allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK3 protein] Ruthenium Red results in decreased activity of TRPA1 protein Ruthenium Red inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [Arachidonic Acid results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein] |
CTD |
PMID:15046718 PMID:15843607 PMID:17684094 PMID:23994502 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions affects binding |
ISO EXP |
Ruthenium Red inhibits the reaction [Capsaicin promotes the reaction [TRPV1 protein results in increased abundance of Calcium]]; Ruthenium Red inhibits the reaction [Sodium affects the reaction [TRPV1 protein results in increased abundance of Calcium]] Ruthenium Red binds to and results in decreased activity of TRPV1 protein; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of TRPV1 mRNA] Ruthenium Red inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium]; Ruthenium Red inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Cobalt]; Ruthenium Red inhibits the reaction [Lidocaine results in increased activity of TRPV1 protein]; Ruthenium Red inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of TRPV1 protein] Ruthenium Red binds to TRPV1 protein |
CTD |
PMID:11140687 PMID:18172555 PMID:18230619 PMID:23264033 PMID:23747933 PMID:30496739 PMID:32652086 More...
|
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
multiple interactions |
EXP ISO |
Ruthenium Red inhibits the reaction [[carvacrol binds to and results in increased activity of TRPV3 protein] which results in increased transport of Calcium] Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of TRPV3 mRNA] |
CTD |
PMID:20086034 PMID:32652086 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|
G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
multiple interactions decreases activity |
EXP |
[Ruthenium Red results in decreased activity of TRPV4 protein] which results in decreased susceptibility to Buthionine Sulfoximine |
CTD |
PMID:20064552 |
|
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Ruthenium Red inhibits the reaction [IGF1 protein results in increased secretion of VEGFA protein] |
CTD |
PMID:20539001 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|